Our News Library | Levin Papantonio - Personal Injury Lawyers

Elmiron: A Failure of Vision

An explosion of recent studies from multiple university medical centers recently exposed that the use of the prescription drug Elmiron® can result in patients’ vision failure, up to and including legal blindness.   Elmiron® is the brand name for pentosane polysulfate sodium (“PPS”), a drug manufactured and distributed by Janssen Pharmaceuticals.   It has been marketed for nearly twenty-five years and resulted in billions of dollars of sales for Janssen.   The earliest clinical trials for Elmiron® from the 1990s revealed not only dubious efficacy, but also a hos

read more

Lawsuits for Vision Problems Caused by Elmiron

With 80 product liability lawsuits already filed and hundreds more likely to follow, lawyers are discussing the coordination of multi-district litigation (MDL). To date, legal action has been taken against Johnson & Johnson’s Janssen Pharmaceuticals Inc., Teva Pharmaceuticals USA Inc., and other pharma companies.

Plaintiffs allege that these companies knowingly withheld risks connected with long-term use of the drug. Complaints list such outcomes as retinal damage and blurred and distorted vision.

read more

Johnson & Johnson to Pay Over $100 Million for Talcum Powder Cancer Lawsuits

After four years of litigation between plaintiffs and Johnson & Johnson, the multinational corporation agreed to the first set of major settlements. The agreement to pay $100 million will resolve more than 1,000 lawsuits in which plaintiffs allege that the talc in Johnson & Johnson’s signature baby powder causes cancer, according to a Bloomberg report.  This settlement marks the first to come from almost 20,000 lawsuits.

read more

Testing Shows 3M Combat Arms Earplugs Totally Inadequate

Aearo Technologies’ Combat Arms earplugs were standard issue for U.S. soldiers fighting in Iraq and Afghanistan. The devices were hailed as groundbreaking technology that enabled soldiers to protect their hearing while still being able to hear commands amidst war zones.

read more

Presiding MDL Judge Denies Summary Judgment As To Most Bard Hernia Mesh Claims

On September 1, 2020, District Judge Edmund A. Sargus, the presiding judge for In re: Davol, Inc./C.R. Bard, Inc., Polypropylene Hernia Mesh Prods. Liab. Litig., MDL No. 2846, issued the summary judgment ruling in the first bellwether trial.   Johns v. C.R. Bard, Inc., is a Ventralight™ ST case which is a defense pick and which is set for trial on January 11, 2021.   The ruling leaves intact nearly all of the plaintiff’s legal theories of relief but trimmed the scope of compensatory damages available to the plaintiff.

read more

EPA Says Chemours Should Switch to Less Dangerous PFAS

When drinking water supplies around Fayetteville, North Carolina proved to be contaminated, all fingers pointed to per- and polyfluoroalkyl substances (PFAS) manufactured at Chemours’ Fayetteville Works plant. U.S. Rep. Richard Hudson, R-N.C. called a roundtable meeting to discuss the pollution. The meeting included various local officials, but the A-list attendee had to have been federal Environmental Protection Agency (EPA) Administrator Andrew Wheeler.

read more

Court Affirms $3.6 Million Jury Verdict for Bard IVC Filter

U.S. Court of Appeals for the Ninth Circuit upheld damages awarded to a patient who suffered heart damage from C.R. Bard’s clot-stopping vein filter. The court ruled that the U.S. Food and Drug Administration’s edicts did not pre-empt Georgia’s state law underscoring a duty to warn.

In 2007, patient Sherr-Una Booker underwent a surgical procedure to place a Bard’s G2 model inferior vena cava (IVC) filter near her heart. When fragments of the filter became detached, Booker was forced to under heart revision surgery.

read more

Class Action Lawsuit Filed Against Geico for Coronavirus Premium Returns

A class-action lawsuit might be taking shape against Geico auto insurance company. When the insurer announced its 15% “Geico Giveback” premium discount program in April, consumers understood it would reflect the dramatic reduction in driving during the COVID-19 crisis. Consumers, however, think the country’s second largest auto insurer undelivered on its promise, and they have taken legal action.

read more

3M’s Legal Defense Rejected by Federal Judge

A federal court judge ruled on Friday, July 24, 2020, that 3M created designs for its Combat Arms Earplugs, Version 2 (CAEv2) without U.S. military input, and so the company cannot use the government contract defense at trial.

In planning their legal strategy, 3M lawyers aimed to invoke the government contract defense, which protects companies from facing liability for defective products that are designed and produced for the federal government.

read more

The Zantac-Cancer Connection

On April 1, 2020, the Food and Drug Administration told companies to stop selling Zantac, and they further urged consumers to throw away any form of the heartburn medicine that might be sitting in household medicine cabinets.

Most stores had already taken Zantac, also known as ranitidine, off their shelves last September when the FDA announced that the drug contains a type of carcinogenic nitrosamine (N-nitrosodimethylamine, or NDMA).

read more

IS YOUR PORTFOLIO STILL DOWN MORE THAN 10 PERCENT IN THE CORONAVIRUS MARKET?

Is Your Portfolio Still Down More Than 10 Percent in the Coronavirus Stock Market? Then Your Advisor Has Some Explaining to Do!

Peter Mougey says you should never accept the "whole market is down" excuse from your advisor. He debunks some common misconceptions about what "the market" really is, what real diversification looks like, and how to push back if you're down more than 10 percent.

read more

KEEPING CALM IN THE CORONAVIRUS MARKET

Keeping Calm in the Coronavirus Market: Eight Guidelines to Help You Make Smart Decisions (at Every Age)

Peter Mougey explains how to avoid knee-jerk, fear-based reactions; how to talk to your financial advisor; and how to make sound decisions that fit your unique circumstances.

read more

Is It Time for a Second Opinion on Your Portfolio?

The market has been super volatile lately. With the coronavirus still wreaking havoc, economic ups and downs, and an election on the horizon, that's not likely to change any time soon. If you're retired or nearing retirement, investors' rights advocate Peter Mougey says you might want to look at a) what's happening with your performance, and b) the make-up of your portfolio.

read more

Doing the (Stock Market) Math: Three Rules for Retired Investors

If you’re making withdrawals from your retirement account, you need to understand the math behind your financial advisor’s strategy. Peter Mougey says you should make sure they are following three critical math rules.

Retirees who make regular withdrawals from their portfolio have specific risks that younger investors don't need to worry about. That's why it's so important to understand the math behind what you're doing—especially in a time of market turmoil like the one we're in now.

read more

Can I Still Live on My Retirement in the Coronavirus Era? Four Questions to Ask Your Advisor Now!

If you're making withdrawals from your retirement account, you need to ask yourself (and your adviser) some tough questions—and to take a good hard look at the numbers.

No doubt about it: The market has had a brutal couple of months. It’s upsetting to check your retirement account and see that some sectors are down as much as 40-50 percent. Granted, some weeks of upswings have been a welcome respite — but is the downward pressure over?

read more

Pages